semaglutide and hidradenitis suppurativa for in Obese Patients Semaglutide improves hidradenitis suppurativa outcomes

Direct pricing at $149/month makes compounded semaglutide accessible regardless of insurance status

Potential Medicare Impact If Medicare Part D covered weight-loss medications without restrictions: Eligible Population: Approximately 15-20 million Medicare beneficiaries meet BMI criteria for anti-obesity medication (BMI 30 or BMI 27 with comorbidities)

This commentary critically evaluates ESSENCE from the perspectives of hepatology research and clinical trial methodology, situates semaglutide within the broader MASLD therapeutic landscape, and explores mechanistic and translational implications for target-organ damage

Mezclar y colocar en un refrigerador a 4C durante la noche

Consuming more than 30 grams of protein in a single meal provides no additional benefits

Descriptive Weight Change by Dose Across both agents, increasing dose was associated with greater reductions in body weight